| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |